{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:23:45Z","timestamp":1773339825965,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jinf.2011.12.015","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T12:35:56Z","timestamp":1325162156000},"page":"424-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Breakthrough invasive mould infections in patients treated with caspofungin"],"prefix":"10.1016","volume":"64","author":[{"given":"Katy-Anna","family":"Phai Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cendrine","family":"Godet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Fekkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Scholler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine","family":"Nivoix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Letscher-Bru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Massias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Kauffmann-Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Elsendoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Uzunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Datry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2011.12.015_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkg117","article-title":"Caspofungin: the first representative of a new antifungal class","volume":"51","author":"Letscher-Bru","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2011.12.015_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/AAC.01292-08","article-title":"Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing","volume":"53","author":"Arendrup","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.12.015_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1399-3062.2007.00252.x","article-title":"Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report","volume":"10","author":"Eschertzhuber","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1469-0691.2009.03050.x","article-title":"High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia","volume":"16","author":"Lafaurie","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2011.12.015_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2007.07.026","article-title":"Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin","volume":"30","author":"Madureira","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2011.12.015_bib6","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1128\/JCM.43.9.4902-4904.2005","article-title":"Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis","volume":"43","author":"Pavie","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.12.015_bib7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"de Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jinf.2005.01.006","article-title":"Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections","volume":"52","author":"Nivoix","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2011.12.015_bib10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/10428190500272499","article-title":"Breakthrough trichosporonosis in patients with acute myeloid leukemia receiving micafungin","volume":"47","author":"Akagi","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jinf.2011.12.015_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s15010-007-6278-6","article-title":"Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin","volume":"36","author":"Bayramoglu","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2011.12.015_bib12","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1086\/341305","article-title":"Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate","volume":"35","author":"Goodman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/500323","article-title":"Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin","volume":"42","author":"Matsue","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib14","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/JCM.02390-09","article-title":"Breakthrough invasive candidiasis in patients on micafungin","volume":"48","author":"Pfeiffer","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.12.015_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/13693786.2010.535179","article-title":"Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature","volume":"49","author":"Schuermans","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2011.12.015_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10156-008-0616-1","article-title":"Breakthrough cryptococcosis in a patient with systemic lupus erythematosus (SLE) receiving micafungin","volume":"14","author":"Suzuki","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jinf.2011.12.015_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1179\/joc.2009.21.2.236","article-title":"Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient","volume":"21","author":"Tascini","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2011.12.015_bib18","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jinf.2007.08.003","article-title":"Mould breakthrough in immunosuppressed adults receiving anidulafungin: a report of 2 cases","volume":"55","author":"Wetzstein","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2011.12.015_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.drup.2006.01.001","article-title":"Update on antifungal drug resistance mechanisms of Aspergillus fumigatus","volume":"8","author":"Chamilos","year":"2005","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jinf.2011.12.015_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","article-title":"Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole","volume":"40","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2011.12.015_bib22","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/AAC.00905-10","article-title":"Population pharmacokinetics and pharmacodynamics of caspofungin in pediatric patients","volume":"55","author":"Li","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.12.015_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2011.12.015_bib24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Viscoli","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2011.12.015_bib25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2011.12.015_bib26","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","article-title":"A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis","volume":"48","author":"Betts","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311006190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311006190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:16:44Z","timestamp":1759007804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445311006190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0163445311006190"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2011.12.015","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breakthrough invasive mould infections in patients treated with caspofungin","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2011.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}